Exploring Autologous CD-19 CAR-Tregs for Rheumatology to Advance Treatment Development for Unmet Diseases
- Explore the role of the immune system in rheumatoid scleroderma
- Hear preclinical evidence from Quell Therapeutics on their novel therapy targeting rheumatoid scleroderma